期刊
NATURE REVIEWS CANCER
卷 3, 期 7, 页码 517-525出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc1120
关键词
-
类别
Most metastatic cancers are fatal. More than 80% of patients with metastatic testicular germ-cell tumours (TGCTs), however, can be cured using cisplatin-based combination chemotherapy. Why are TGCTs more sensitive to chemotherapeutics than most other tumour types? Answers to this question could lead to new treatments for metastatic cancers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据